Global Advanced Therapeutics Pharmaceutical Outsourcing Market Anticipated To Grow To $10.73 Billion By 2030 At 5% CAGR
The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Expected Market Value Outlook For The Advanced Therapeutics Pharmaceutical Outsourcing Market Through 2030?
The advanced therapeutics pharmaceutical outsourcing market has shown consistent expansion in recent years. It is forecast to increase from $8.41 billion in 2025 to $8.82 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.0%. This historical growth can be attributed to several factors including an expanding biologics pipeline, the high cost associated with in-house manufacturing, the rising incidence of oncology and rare diseases, a scarcity of internal expertise in advanced therapies, and the increasing globalization of clinical trials.
The advanced therapeutics pharmaceutical outsourcing market is projected to experience substantial expansion in the coming years, reaching a valuation of $10.73 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.0%. This anticipated growth during the forecast period is primarily fueled by factors such as the increasing adoption of personalized medicine, the broadening of commercial-scale cell and gene therapies, the rising complexity of regulations, a surge in funding for biotech start-ups, and the imperative for quicker time-to-market. Key trends anticipated over this period encompass the escalating outsourcing of cell and gene therapy manufacturing, a growing need for comprehensive CDMO services, the development of specialized viral vector production capabilities, an intensified focus on regulatory and quality compliance assistance, and the expedited outsourcing of clinical trials for uncommon and intricate indications.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13768&type=smp
Which Major Factors Are Contributing To The Development Of The Advanced Therapeutics Pharmaceutical Outsourcing Market?
The anticipated expansion of the advanced therapeutics pharmaceutical outsourcing market is linked to the rising acceptance of cell and gene therapies. These therapies represent cutting-edge medical approaches, leveraging live cells or genetic material to address or eliminate diseases. Within cell and gene therapy development, advanced therapeutics pharmaceutical outsourcing facilitates access to highly qualified providers and skilled staff, thereby conserving corporate time and resources that would otherwise be spent on internal team development. Illustratively, data from March 2024, supplied by IQVIA Holdings Inc., a US-based firm specializing in advanced analytics, technology solutions, and clinical research services for the life sciences and healthcare sectors, revealed that worldwide expenditure on cell and gene therapies dramatically rose to $5.9 billion in 2023, marking a 38% increase compared to 2022. Consequently, the expanding embrace of cell and gene therapies is a primary catalyst for the growth observed in the advanced therapeutics pharmaceutical outsourcing market.
What Key Segment Areas Are Included In The Advanced Therapeutics Pharmaceutical Outsourcing Market Assessment?
The advanced therapeutics pharmaceutical outsourcing market covered in this report is segmented –
1) By Service Type: Contract Research Organizations (CROs), Contract Development And Manufacturing Organizations (CDMOs)
2) By Indication: Oncology, Neurology, Other Indications
3) By Therapy: Cell Therapy, Gene Therapy, RNA-based Therapies
4) By Application: Preclinical Services, Clinical Services, Commercial Manufacturing And Packaging
Subsegments:
1) By Contract Research Organizations (CROs): Preclinical Research Services, Clinical Trial Management Services, Regulatory Affairs Services, Data Management And Biostatistics
2) By Contract Development And Manufacturing Organizations (CDMOs): Drug Development Services, Formulation Development, Analytical Testing Services, Commercial Manufacturing Services
Which Trends Are Expected To Shape The Advanced Therapeutics Pharmaceutical Outsourcing Market?
Leading companies operating within the advanced therapeutics pharmaceutical outsourcing market are increasingly focusing on strategic collaborations to deliver dependable services to customers. A strategic partnership represents a cooperative arrangement between two or more entities, typically businesses, designed to achieve mutually beneficial aims that each participant would be unable to reach independently. For example, in January 2023, Lonza, a Switzerland-based manufacturing firm for the pharmaceutical, biotechnology, and nutrition industries, entered into a partnership with Context Therapeutics Inc., a US-based biopharmaceutical company focused on developing medicines for solid tumors. This collaboration entails Lonza providing manufacturability assessment, gene and cell line construction, and process development services for both the drug substance and the final drug product.
Who Are The Major Companies Operating In The Advanced Therapeutics Pharmaceutical Outsourcing Market?
Major companies operating in the advanced therapeutics pharmaceutical outsourcing market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, IQVIA, ICON plc, SGS SA, Lonza Group, Parexel International Corporation, WuXi AppTec, Syneos Health, Catalent Inc., Charles River Laboratories International, Recipharm AB, Samsung Biologics, Vetter Pharma International GmbH, Medpace Holdings Inc., Fujifilm Diosynth Biotechnologies, AGC Biologics, Evotec SE, Piramal Pharma Solutions, Corden Pharma International LLC, Novotech Pty Ltd., Cytovance Biologics
Access The Complete Advanced Therapeutics Pharmaceutical Outsourcing Market Report:
Which Region Contributes The Most To The Advanced Therapeutics Pharmaceutical Outsourcing Market?
North America was the largest region in the advanced therapeutics pharmaceutical outsourcing market in 2025. The regions covered in the advanced therapeutics pharmaceutical outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Advanced Therapeutics Pharmaceutical Outsourcing Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=13768&type=smp
Browse Through More Reports Similar to the Global Advanced Therapeutics Pharmaceutical Outsourcing Market 2026, By The Business Research Company
Advanced Therapeutics Pharmaceutical Outsourcing Market Report 2026
Pharmaceutical Fill And Finish Outsourcing Market Report 2026
Biologics Outsourcing Market Report 2026
https://www.thebusinessresearchcompany.com/report/biologics-outsourcing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
